We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

142 hedge funds and large institutions have $735M invested in Cardiovascular Systems, Inc. in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $1.7M | Put options by funds: $541K

10% less funds holding

Funds holding: 157142 (-15)

10% less capital invested

Capital invested by funds: $813M → $735M (-$77.7M)

26% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 58

54% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 24

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
142
Holders Change
-15
Holders Change %
-9.55%
% of All Funds
3.54%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
43
Reduced
58
Closed
24
Calls
$1.7M
Puts
$541K
Net Calls
+$1.16M
Net Calls Change
+$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$6.06M -$288K -9,458 -4%
Charles Schwab
27
Charles Schwab
California
$5.68M -$5.26K -173 -0.1%
HSA
28
Hussman Strategic Advisors
Maryland
$5.63M
MPAM
29
Monarch Partners Asset Management
Massachusetts
$5.45M -$277K -9,120 -4%
RI
30
Redwood Investments
Massachusetts
$5.44M -$757K -24,891 -11%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$5.43M -$493K -16,193 -8%
Morgan Stanley
32
Morgan Stanley
New York
$5.21M +$1.79M +58,999 +47%
Thrivent Financial for Lutherans
33
Thrivent Financial for Lutherans
Minnesota
$4.31M
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$4.03M +$155K +5,080 +4%
Two Sigma Investments
35
Two Sigma Investments
New York
$3.74M -$5.13M -168,653 -56%
Citadel Advisors
36
Citadel Advisors
Florida
$3.54M -$80.9K -2,660 -2%
USAA
37
United Services Automobile Association
Texas
$3.2M
NFA
38
Nationwide Fund Advisors
Ohio
$3.13M
TA
39
Teton Advisors
New York
$3.13M
SCA
40
Secor Capital Advisors
New York
$2.78M +$1.9M +62,599 +173%
QI
41
QS Investors
New York
$2.75M -$59.9K -1,970 -2%
GKIM
42
GW&K Investment Management
Massachusetts
$2.7M +$2.91M +95,765 New
NI
43
Numeric Investors
Massachusetts
$2.67M -$3.77M -123,919 -57%
HI
44
HBK Investments
Texas
$2.55M -$1.12M -36,742 -29%
MC
45
Menta Capital
California
$2.49M -$745K -24,510 -22%
EIM
46
Essex Investment Management
Massachusetts
$2.46M -$15.8K -519 -0.6%
GI
47
GAMCO Investors
Connecticut
$2.29M +$1.21M +39,930 +96%
Goldman Sachs
48
Goldman Sachs
New York
$2.17M -$1.62M -53,195 -41%
MPI
49
Mairs & Power Inc
Minnesota
$2.13M
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.98M

CSII Hedge Fund Activity: Q3 2017 in Review

142 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2017, worth a combined $735M — down 9.6% from $813M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of CSII and 11 opened new positions — a net loss of 13 holders — while 58 trimmed existing stakes and 43 added.

The largest buyer was Wellington Management Group, adding an estimated $26M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $12.9M sold.

  • 142 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2017, down from 157 in Q2 2017.
  • Funds reported $735M of Cardiovascular Systems, Inc. stock for Q3 2017, down 9.6% quarter-over-quarter.
  • 11 funds opened new Cardiovascular Systems, Inc. positions in Q3 2017 and 24 closed out, a net change of -13 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2017 was Wellington Management Group, an estimated $26M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2017 was Driehaus Capital Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q3 2017.